Project Details
Abstract
Nanog has been shown to specifically expressed in undifferentiated embryonic stem (ES)
cells and has been shown to be essential for the maintenance of pluripotency of the ES cells.
Nanog is highly expressed in ES cells and embryonic carcinoma (EC) cells, and is usually not
expressed in adult tissues, suggesting its role in regulating cell differentiation. In our
preliminary studies, we examined the activity of PKC-α and PKC-δ, two PKC isoforms
believed to be involved in the regulation of cell differentiation and proliferation, to see if their
activity influence Nanog expression. We found that PKC-αdownregulates Nanog expression
in human masopha ryngeal carcinoma cell NPC 076 through downregulating Oct4 and Sox2.
More over, treatment of PKC activator or ectopic expression of PKCsuppressed the Nanog
expression in Nanog expressing human embryonal carcinoma cell line NT2/D1. Based on our
preliminary results, we suggest that PKC may be a negative regulator for Nanog expression in
human embryonic stem cell. Recently mir-302 family of miRNAs (mir-302s) were shown to
be specifically expressed in ESCs and pluripotent cells and were suggested to target many cell
cycle regulators during early embryonic development. In view of these, it is very likely that
mir-302s may play critical roles in ES cell maintenance and renewal. Since both
Nanog/Oct4/Sox2 and mir-302s appeared to play roles in cell cycle regulation and
differentiation of the pluripotent cells. We hypothesize that there might be cross-talks in
between these two signaling cascades.
In this proposal, we intend to delineate the mechanism underlying the regulation of Nanog
expression by PKCs. We will be using human embryonic stem cell and embryonal carcinoma
cell to do the study. In addition, the possible involvement of microRNA in
PKC/Naong/Oct4/Sox2 regulation will also be examined. Understanding the regulation of
Nanog expression should shed light in our understanding of the maintenance of the ES cell
pluripotency. In this proposal, we present some of our preliminary results and propose our
future works along this line of the research work.
Project IDs
Project ID:PC9907-2535
External Project ID:NSC99-2314-B182-033
External Project ID:NSC99-2314-B182-033
Status | Finished |
---|---|
Effective start/end date | 01/08/10 → 31/07/11 |
Keywords
- Nanog
- PKC
- nasopharyngeal carcinoma cell line
- human embryonal carcinoma cell line
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.